Yes, Ambien is still on the market. Both the brand-name version, manufactured by Sanofi, and multiple generic versions (sold as zolpidem tartrate) remain FDA-approved and available by prescription in the United States. There are no active shortages listed in the FDA’s drug shortage database.
Brand-Name and Generic Options
Sanofi continues to manufacture brand-name Ambien at its Bridgewater, New Jersey facility. The brand-name drug comes in 5 mg and 10 mg immediate-release tablets. An extended-release version, Ambien CR, is also available in 6.25 mg and 12.5 mg strengths.
Most people today take generic zolpidem rather than the brand-name product, largely because of cost. Generic versions have been on the market since 2007, when the FDA approved formulations from Teva, Sandoz, and several other manufacturers. Today, at least a dozen companies produce generic zolpidem, including Lupin Pharmaceuticals, Torrent Pharmaceuticals, Aurobindo Pharma, and Watson Laboratories. Your pharmacy will typically dispense whichever generic it stocks unless your prescriber specifically requests the brand name.
Why You Might Think It Was Pulled
Ambien has drawn significant regulatory scrutiny over the past decade, which may be why some people wonder whether it’s been taken off the market. It hasn’t been removed, but it has received two major safety updates that changed how it’s prescribed.
In 2013, the FDA took the unusual step of requiring different starting doses for women and men. The agency found that zolpidem clears from the body more slowly in women, leaving enough of the drug in the bloodstream to impair driving the next morning. The recommended starting dose for women was cut in half: from 10 mg to 5 mg for immediate-release Ambien, and from 12.5 mg to 6.25 mg for the extended-release version. Men can still be prescribed the higher doses, though the FDA encourages prescribers to consider starting at the lower dose for them as well.
Then in 2019, the FDA added its most serious safety label, a boxed warning, to Ambien and all other zolpidem products. The warning addresses complex sleep behaviors: sleepwalking, sleep driving, and performing other activities while not fully awake. These episodes are rare, but they have caused serious injuries and deaths. If you’ve ever experienced one of these episodes while taking any sleep medication in the same drug class, you should not be prescribed zolpidem again.
How It’s Classified Today
Ambien is a Schedule IV controlled substance under federal law, the same category as Valium, Xanax, and Ativan. That classification means the government considers it to have a low but real potential for abuse and dependence. You need a prescription to obtain it, and your prescriber may limit the quantity or number of refills depending on state regulations.
Current Dosing Recommendations
The FDA’s current dosing guidelines reflect the 2013 changes and apply to all zolpidem products, whether brand-name or generic.
- Immediate-release (Ambien): Women start at 5 mg taken once at bedtime. Men start at 5 mg or 10 mg. Either can increase to 10 mg if the lower dose isn’t effective, but the higher dose carries a greater risk of next-morning grogginess.
- Extended-release (Ambien CR): Women start at 6.25 mg. Men start at 6.25 mg or 12.5 mg. The same trade-off applies: higher doses work better for some people but are more likely to impair alertness the following morning.
These doses are for non-elderly adults. Older adults and people with liver problems are generally started at the lowest available dose because the drug takes longer to leave their systems.
What’s Changed in Practice
While Ambien remains fully available, the way doctors prescribe it has shifted. The boxed warning and dosing changes have made many prescribers more cautious. Some prefer to try other approaches first, including newer sleep medications or cognitive behavioral therapy for insomnia. Zolpidem is still one of the most commonly prescribed sleep aids in the country, but you may find that your doctor starts you at a lower dose than in years past, limits the duration of your prescription, or discusses the risks of complex sleep behaviors before writing a script.
If you currently take Ambien or generic zolpidem and have had no issues, there’s no supply-side reason to worry about losing access. The drug is widely manufactured, not on any shortage list, and remains an FDA-approved treatment for insomnia.